US Physical Therapy (NYSE: USPH) reported Q1 EPS of $0.64, $0.23 better than the analyst estimate of $0.41. Revenue for the quarter came in at $112.4 million versus the consensus estimate of $109.7 million.

GUIDANCE:

US Physical Therapy sees FY2021 EPS of $2.68-$2.78, versus the consensus of $2.56.

• Management increased its range of earnings guidance for 2021 to Operating Results per share of $2.68 to $2.78 from the previous range of $2.40 to $2.52 due to better than expected performance in the 2021 First Quarter, the impact of the acquisition closed in the 2021 First Quarter, and the extension of 2% sequestration relief on Medicare payments through December 31, 2021 (previously scheduled to end on March 31, 2021).

For earnings history and earnings-related data on US Physical Therapy (USPH) click here.